AI-supported omnichannel design, therapeutic-area CRM content, and MSL adaptation programmes that turn every HCP interaction into strategy-aligned, measurable evidence.
Medical affairs runs on conversations that don't show up in dashboards. Field visits, scientific exchanges, KOL relationships, congress-floor dialogue. The value created lives in interactions finance can't see and leadership can't easily reward.
The studio designs the instruments (AI-supported omnichannel architecture, therapeutic-area CRM content, MSL adaptation programmes) that finally make that work countable, comparable, and strategically aligned.
Context: You are launching a new indication in the Rare Disease segment. Your MSLs report heavy field resistance. Regional KOLs are deferring treatment adoption, citing the absence of Local Real-World Evidence (RWE) and dismissing global data as non-representative.
MD. Medical affairs practitioner. Contributing to the discipline's capability standards through the Medical Affairs Professional Society (MAPS): Faculty for the EMEA leadership workshops, Mentor in the MAPS Mentorship Programme, and Competency Team member shaping the field's professional benchmarks.
Every framework on this site was built in field reality first, then turned into an instrument a team can deploy. No theory imported from outside the room.